4//SEC Filing
DeSieno Alexis 4
Accession 0001666071-25-000116
CIK 0001666071other
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 6:36 PM ET
Size
9.3 KB
Accession
0001666071-25-000116
Insider Transaction Report
Form 4
Cardlytics, Inc.CDLX
DeSieno Alexis
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2025-07-01+14,349→ 179,182 total - Sale
Common Stock
2025-07-02$1.78/sh−7,324$13,056→ 171,858 total - Exercise/Conversion
Restricted Stock Units
2025-07-01−14,349→ 43,049 total→ Common Stock (14,349 underlying)
Footnotes (4)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer.
- [F2]Shares were sold solely to satisfy tax withholding obligations that resulted from the delivery of shares of common stock for RSUs that vested on July 1, 2025. The Reporting Person did not sell shares for any other purpose.
- [F3]The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $1.66 to $1.8451, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3).
- [F4]The RSU award was originally for 114,796 shares. The RSU award vested or will vest in eight equal installments on July 1, 2024, October 1, 2024, January 1, 2025, April 1, 2025, July 1, 2025, October 1, 2025, January 1, 2026 and April 1, 2026, provided that the Reporting Person remains employed by the Issuer on such vesting date.
Documents
Issuer
Cardlytics, Inc.
CIK 0001666071
Entity typeother
Related Parties
1- filerCIK 0001987391
Filing Metadata
- Form type
- 4
- Filed
- Jul 1, 8:00 PM ET
- Accepted
- Jul 2, 6:36 PM ET
- Size
- 9.3 KB